{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:50:49Z","timestamp":1785336649598,"version":"3.55.0"},"reference-count":31,"publisher":"Wiley","issue":"13","license":[{"start":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T00:00:00Z","timestamp":1294617600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2011,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND:<\/jats:title><jats:p>Recent genetic studies have implicated p53 mutation as a significant risk factor for therapeutic failure in squamous cell carcinoma of the head and neck (SCCHN). However, in a recent meta\u2010analysis in the literature of p53 from major anatomical subsites (larynx, oral cavity, oropharynx\/hypopharynx), associations between patient survival and p53 status were ambiguous.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS:<\/jats:title><jats:p>The authors examined a cohort of SCCHNs using a previously developed biomarker combination that likely predicts p53 status based on p53\/MDM2 expression levels determined by immunohistochemistry (IHC). In addition, the authors generated and validated an antibody to MTBP (an MDM2 binding protein that alters p53\/MDM2 homeostasis and may contribute to metastatic suppression) and have incorporated data for MTBP expression into the current analyses.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS:<\/jats:title><jats:p>Analysis of expression data for p53 and MDM2 in 198 SCCHN patient samples revealed that the biomarker combination p53 + ve\/MDM2\u2010low (likely indicative of p53 mutation) was significantly associated with reduced overall survival (log\u2010rank <jats:italic>P<\/jats:italic> = .035) and was an independent prognostic factor (<jats:italic>P<\/jats:italic> = .013; HR, 1.705; 95% CI, 1.12\u20102.60); thus, these data were compatible with earlier genetic analyses. By using IHC for p53 and MDM2 to dichotomize patients, the authors found that loss of MTBP expression was significantly associated with reduced survival (log\u2010rank <jats:italic>P<\/jats:italic> = .004) and was an independent prognostic factor (<jats:italic>P<\/jats:italic> = .004; HR, 2.78; 95% CI, 1.39\u20105.54) in p53 + ve\/MDM2\u2010low patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS:<\/jats:title><jats:p>These results represent the first examination of MTBP expression in human tissues and provide evidence for a p53 status\u2010dependent role for MTBP in suppressing disease progression in SCCHN patients as well as confirming a role for p53 pathway function in delaying disease progression. Cancer 2011. \u00a9 2011 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.25864","type":"journal-article","created":{"date-parts":[[2011,1,10]],"date-time":"2011-01-10T17:13:23Z","timestamp":1294679603000},"page":"2939-2950","source":"Crossref","is-referenced-by-count":21,"title":["Loss of MTBP expression is associated with reduced survival in a biomarker\u2010defined subset of patients with squamous cell carcinoma of the head and neck"],"prefix":"10.1002","volume":"117","author":[{"given":"Nikolina","family":"Vlatkovi\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"El\u2010Fert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Devling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arpita","family":"Ray\u2010Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Gore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos P.","family":"Rubbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim R.","family":"Helliwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,1,10]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601373"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2006.01236_10.x"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cancergencyto.2005.06.008"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/path.1838"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2002.06.161"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archotol.1996.01890190065015"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-09-0981"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-4486.2006.01236_8.x"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602358"},{"key":"e_1_2_6_11_2","first-page":"993","article-title":"MDM2, an introduction","volume":"1","author":"Iwakuma T","year":"2003","journal-title":"Mol Cancer Res."},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.7.7a.1126"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004252200"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.25.2.545-553.2005"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1157-03"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hed.20254"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1517\/17530059.2.9.1013"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2273.1998.00087.x"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210302"},{"key":"e_1_2_6_20_2","first-page":"4070","article-title":"p53 mutations in squamous cell carcinoma of the head and neck predominate in a subgroup of former and present smokers with a low frequency of genetic instability","volume":"57","author":"Liloglou T","year":"1997","journal-title":"Cancer Res."},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199503163321104"},{"key":"e_1_2_6_22_2","first-page":"1043","article-title":"Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck","volume":"1","author":"Gonzalez MV","year":"1995","journal-title":"Clin Cancer Res."},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa073770"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh183"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)64569-5"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2007.03.005"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/358080a0"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2004.11.022"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1080\/00016480701724904"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210827"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.82"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.07112"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.25864","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.25864","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T10:46:04Z","timestamp":1760265964000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.25864"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,10]]},"references-count":31,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["10.1002\/cncr.25864"],"URL":"https:\/\/doi.org\/10.1002\/cncr.25864","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"value":"0008-543X","type":"print"},{"value":"1097-0142","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,10]]}}}